clinical trial · NCT06916325
Open Label Trial of Deceased Donor Livers Transplanted After DHOPE With eXVIVO LIVER Perfusion
XVIVO Perfusion·N/A·not yet recruiting·n = 215
Liver Transplant SurgeryLiver Transplantationdual hypothermic oxygenated perfusion (DHOPE)
brief summary
The purpose of this clinical study is to confirm the safety and effectiveness of dual hypothermic oxygenated perfusion (DHOPE) using the Liver Assist to preserve deceased donor livers for transplantation.
started
Jan 1, 2027
primary completion
Oct 1, 2028
completion
Apr 1, 2033
last updated
Apr 21, 2026
official title
DeLIVER Trial: A Prospective, Multi-Center, Single-Arm, Open Label Trial of Deceased Donor Livers Transplanted After DHOPE With eXVIVO LIVER Perfusion
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol